Site navigation

Navigation

Diabetes (type 2) - pioglitazone (replaced by TA63)

Summary

This guidance has been replaced by Diabetes (type 2) - glitazones (review).


Guidance documents

  • No documents found

Implementing this guidance

  • None available

Other information

About this guidance

Technology appraisals TA21

Issued: March 2001

How this guidance was produced

See also:

Order printed copies of this guidance